Analysis Alligator Bioscience: Loss of important partner

Despite clinical progress for  ADC-1013 the partner Janssen has chosen to return the project. Alligator intends to continue development and sees good opportunities to find a new partner. Until the strategy has cleared we lower fair value with some 20 per cent.

Read the full report (Swedish) here.